Investigational ALS drug prolongs patient survival in clinical trial

An experimental medication that was recently shown to slow the progression of amyotrophic lateral sclerosis has now demonstrated the potential to also prolong patient survival. The findings come from a recent clinical trial.

source https://www.sciencedaily.com/releases/2020/10/201016112859.htm